Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel biotin-specific monoclonal antibody and use thereof

Inactive Publication Date: 2019-10-24
ROCHE DIAGNOSTICS OPERATIONS INC
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a monoclonal antibody that specifically binds to a compound of Formula I. This antibody can be used in various methods for measuring the compound in a sample. The technical effect of this patent is the development of a reliable and accurate method for measuring the compound of Formula I in a sample.

Problems solved by technology

Biotin comprised in a sample, if present at high levels might interfere in an assay for measurement of an analyte, which is employing a (strept)avidin coated solid phase and a biotinylated specific binding agent.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel biotin-specific monoclonal antibody and use thereof
  • Novel biotin-specific monoclonal antibody and use thereof
  • Novel biotin-specific monoclonal antibody and use thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Derivatization of Biotin at the C5 Atom of the Thiophene Ring and Synthesis Steps to Obtain an Immunogen

[0178]1.1

From biotin [1] to compound [2]; see FIG. 2 A

(S)-5-((1S,6R)-2-Oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentanoic Acid Methyl Ester [2]

[0179](S. A. Sundberg, R. W. Barrett, M. Pirrung, A. L. Lu, B. Kiangsoontra, C. P. Holmes J. Am. Chem. Soc. 1995, 117(49), 12050-12057) Acetyl chloride (7.50 mL) was slowly added to stirred dry methanol (160 mL) at 0° C. under an argon gas atmosphere. The resulting mixture was stirred for 30 min at room temperature. Then, biotin ([1], 6.00 g, 24.6 mmol) was added in one portion and stirring was continued overnight. After concentrating in vacuo, the crude product was re-dissolved in a mixture of CH2Cl2 and methanol (200 mL, v / v=95:5) and washed with saturated aqueous NaHCO3 solution. The aqueous phase was then re-extracted with a mixture of CH2Cl2 and methanol (100 mL, v / v=95:5, 3 times). The combined organic layers were dried over Na2SO4 a...

example 2

Synthesis of a Reagent for Screening Monoclonal Antibodies In Vitro

[0303]2.1

[0304]The screening reagent [30] was synthesized by using standard reaction conditions, by reacting the NHS ester [24] described above with an amino derivative of digoxigenine like Card-20(22)-enolide, 3-[2-[[2-[2-(2-aminoethoxy)ethoxy]ethyl] amino]-2-oxoethoxy]-12,14-dihydroxy-, (3β,5β,12β)-(9CI), CAS Registry Number 185523-10-8, which was synthesized as described in EP 0747447, with the NHS ester described above in DMF for 2 h at room temperature. Afterwards the solvent was removed and the product isolated by preparative HPLC chromatography. The structure of [30] is also shown in FIG. 2L.

2.2

5-[(3aS,4S,6R,6aR)-6-(2-{2-[2-(2-Amino-ethoxy)-ethoxy]-ethoxy}-ethoxy)-2-oxo-hexahydro-thieno[3,4-d]imidazol-4-yl]-pentanoic Acid

[0305]Biotin derivative [16] (5.00 mg, 11.4 μmol, 1.00 eq.) was dissolved in methanol (1.0 mL) under an argon gas atmosphere. Thereto, Pd / C (17 mg, 1.50 eq., 10 wt-% Pd) was added and the resu...

example 3

Derivatization of Biotin at the N′1 Atom and Synthesis of a Screening Reagent

(1) FMOC-Beta-Alanine-Acid Chloride

[0313]To 4.7 g FMOC-beta-alanine (IRIS, FAA1300) in a flask under dry conditions ca. 20 mL thionyl chloride were added slowly. The mixture was stirred at room temperature for 50 min. and afterwards heated to reflux for 10 min. After cooling, the mixture was evaporated, the residue was dissolved in absolute toluene three times and evaporated each time.

[0314]The yield was 5.1 g.

(2) FMOC-Beta-Alanyl-Biotin

[0315]The carboxylic acid of biotin was protected by reacting biotin (2.48 g) with t-butylchlorodiphenylsilane (6.5 ml) in 15 mL dry pyridine in the presence of DMAP (0.63 g) overnight at room temperature in an inert atmosphere of argon as described by Fang and Bergstrom in Nucleic Acids Research, 2003, Vol. 31, No. 2, 708.

[0316]4.9 g FMOC-beta-alanine-acid chloride dissolved in 10 mL dichloromethane were added and stirred for 3.5 h at room temp. The mixture was evaporated, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Digital informationaaaaaaaaaa
Molar densityaaaaaaaaaa
Molar densityaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a monoclonal antibody capable of binding to biotin. In one embodiment the monoclonal antibody according to the invention also does not bind to a biotin moiety on a biotinylated molecule, wherein the biotin moiety is attached to the molecule via the carbon atom of the carboxyl function of the valeric acid moiety of biotin. Also disclosed is a method for generation of an antibody as disclosed herein. The monoclonal antibody according to the invention is of specific use in a method for measuring an analyte in a sample, wherein a (strept)avidin / biotin pair is used to bind a biotinylated analyte specific binding agent to a (strept)avidin coated solid phase.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of International Application No. PCT / EP2017 / 084541 filed Dec. 22, 2017, which claims priority to European Application No. 16206944.7 filed Dec. 27, 2016, European Application No. 17184141.4 filed Jul. 31, 2017, and European Application No. 17184142.2 filed Jul. 31, 2017, the disclosures of which are hereby incorporated by reference in their entirety.BACKGROUND OF THE INVENTION[0002]The present invention relates to a monoclonal antibody capable of binding to biotin. In one embodiment the monoclonal antibody according to the invention also does not bind to a biotin moiety on a biotinylated molecule, wherein the biotin moiety is attached to the molecule via the carbon atom of the carboxyl function of the valeric acid moiety of biotin. Also disclosed is a method for generation of an antibody as disclosed herein. The monoclonal antibody according to the invention is of specific use in a method for measuring a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/543C07K16/44
CPCC07K16/44G01N33/54306C07K16/00C07K16/40C07K2317/34C07K2317/92C07D495/04C07K14/43504G01N33/82C07K2319/92
Inventor GERG, MICHAELHEINDL, DIETERHILLRINGHAUS, LARSHIRZEL, KLAUSHOJER, CAROLINE DOROTHEAHUBER, FLORIANJOSEL, HANS-PETERMEIER, THOMASSCHRAEML, MICHAELVOSS, EDGAR
Owner ROCHE DIAGNOSTICS OPERATIONS INC